Collaboration to Identify Autoimmune Markers

An agreement to collaborate on the identification of genetic markers associated with an autoimmune disease has been announced by GenData Research Corp. (Salt Lake City, UT) and Celera Diagnostics (Alameda, CA, USA).

GenData will provide Celera Diagnostics with DNA samples from affected patients, corresponding clinical data, and well-matched controls from its comprehensive biomedical research repository that integrates biologic samples with decades of medical and genetic information from population-based studies and from studies on multigenerational families. Celera Diagnostics plans to analyze these samples in order to identify genetic markers of the disease. Financial terms were not disclosed.

"This agreement with GenData will provide Celera Diagnostics with samples and high-quality clinical data combined with the scientific experience of leaders in the areas of autoimmune disease and human genetics,” said Linda MacAllister, M.D., Ph.D., director, medical genetics, Celera Diagnostics.

GenData is a commercial contract research and licensing partner of the University of Utah (Salt Lake City, USA). The company's key asset is its ability to provide commercial access to research using the Utah Population Database: an integrated accumulation of more than seven million linked records, including genealogic records, population records, and vital statistics, all linked to medical information.



Related Links:
GenData
Celera Diagnostics